APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hepatitis A immunoglobulin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Hepatitis A immunoglobulin Industry Growth and Trends Forecast to 2032

29 December 2025101 pages

Choose your research edition.

Industry ResearchHepatitis A immunoglobulin Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepatitis A immunoglobulin Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Hepatitis A immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepatitis A immunoglobulin Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepatitis A immunoglobulin Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Hepatitis A immunoglobulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hepatitis A immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hepatitis A immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hepatitis A immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hepatitis A immunoglobulin include CSL Behring, Dr. Reddy's Laboratories, Native Antigen, AIM Vaccine, GSK, Sinovac Biotech, Merck, Pukang Biotechnology and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hepatitis A immunoglobulin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hepatitis A immunoglobulin market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hepatitis A immunoglobulin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hepatitis A immunoglobulin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hepatitis A immunoglobulin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hepatitis A immunoglobulin Market by Company

CSL Behring

Dr. Reddy's Laboratories

Native Antigen

AIM Vaccine

GSK

Sinovac Biotech

Merck

Pukang Biotechnology

Sanofi

Changchun Lnstitute Of Biological Products

Zhifei Biological Products

Hepatitis A immunoglobulin Segment by Type

Inactivated

Attenuated

Hepatitis A immunoglobulin Segment by Application

Hospital

Pharmacy

Other

Hepatitis A immunoglobulin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis A immunoglobulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepatitis A immunoglobulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis A immunoglobulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hepatitis A immunoglobulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hepatitis A immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Inactivated Table 2. Major Company of Attenuated Table 3. Global Hepatitis A immunoglobulin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Hepatitis A immunoglobulin Sales by Type (2021-2026) & (Units) Table 5. Global Hepatitis A immunoglobulin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Hepatitis A immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Hepatitis A immunoglobulin Sales Market Share in Value by Type (2021-2026) Table 8. Global Hepatitis A immunoglobulin Price by Type (2021-2026) & (US$/Unit) Table 9. Global Hepatitis A immunoglobulin Sales by Type (2027-2032) & (Units) Table 10. Global Hepatitis A immunoglobulin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Hepatitis A immunoglobulin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Hepatitis A immunoglobulin Sales Market Share in Value by Type (2027-2032) Table 13. Global Hepatitis A immunoglobulin Price by Type (2027-2032) & (US$/Unit) Table 14. North America Hepatitis A immunoglobulin Sales by Type (2021-2026) & (Units) Table 15. North America Hepatitis A immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Hepatitis A immunoglobulin Sales by Type (2021-2026) & (Units) Table 17. Europe Hepatitis A immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Hepatitis A immunoglobulin Sales by Type (2021-2026) & (Units) Table 19. Asia-Pacific Hepatitis A immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Hepatitis A immunoglobulin Sales by Type (2021-2026) & (Units) Table 21. Latin America Hepatitis A immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Hepatitis A immunoglobulin Sales by Type (2021-2026) & (Units) Table 23. Middle East and Africa Hepatitis A immunoglobulin Sales by Type (2021-2026) & (US$ Million) Table 24. Hepatitis A immunoglobulin Industry Trends Table 25. Hepatitis A immunoglobulin Industry Drivers Table 26. Hepatitis A immunoglobulin Industry Opportunities and Challenges Table 27. Hepatitis A immunoglobulin Industry Restraints Table 28. Global Hepatitis A immunoglobulin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Hepatitis A immunoglobulin Revenue Market Share by Company (2021-2026) Table 30. Global Hepatitis A immunoglobulin Sales by Company (2021-2026) & (Units) Table 31. Global Hepatitis A immunoglobulin Sales Share by Company (2021-2026) Table 32. Global Hepatitis A immunoglobulin Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Hepatitis A immunoglobulin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Hepatitis A immunoglobulin Major Company Production Sites and Headquarters Table 35. Global Hepatitis A immunoglobulin Company, Product Type & Application Table 36. Global Hepatitis A immunoglobulin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Hepatitis A immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Hepatitis A immunoglobulin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Hepatitis A immunoglobulin Sales by Region (2021-2026) & (Units) Table 41. Global Hepatitis A immunoglobulin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Hepatitis A immunoglobulin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Hepatitis A immunoglobulin Sales Market Share in Value by Region (2021-2026) Table 44. Global Hepatitis A immunoglobulin Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Hepatitis A immunoglobulin Sales by Region (2027-2032) & (Units) Table 46. Global Hepatitis A immunoglobulin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Hepatitis A immunoglobulin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Hepatitis A immunoglobulin Sales Market Share in Value by Region (2027-2032) Table 49. Global Hepatitis A immunoglobulin Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Hepatitis A immunoglobulin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Hepatitis A immunoglobulin Sales by Application (2021-2026) & (Units) Table 52. Global Hepatitis A immunoglobulin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Hepatitis A immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Hepatitis A immunoglobulin Sales Market Share in Value by Application (2021-2026) Table 55. Global Hepatitis A immunoglobulin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Hepatitis A immunoglobulin Sales by Application (2027-2032) & (Units) Table 57. Global Hepatitis A immunoglobulin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Hepatitis A immunoglobulin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Hepatitis A immunoglobulin Sales Market Share in Value by Application (2027-2032) Table 60. Global Hepatitis A immunoglobulin Price by Application (2027-2032) & (US$/Unit) Table 61. North America Hepatitis A immunoglobulin Sales by Application (2021-2026) & (Units) Table 62. North America Hepatitis A immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Hepatitis A immunoglobulin Sales by Application (2021-2026) & (Units) Table 64. Europe Hepatitis A immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Hepatitis A immunoglobulin Sales by Application (2021-2026) & (Units) Table 66. Asia-Pacific Hepatitis A immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Hepatitis A immunoglobulin Sales by Application (2021-2026) & (Units) Table 68. Latin America Hepatitis A immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Hepatitis A immunoglobulin Sales by Application (2021-2026) & (Units) Table 70. Middle East and Africa Hepatitis A immunoglobulin Sales by Application (2021-2026) & (US$ Million) Table 71. CSL Behring Company Information Table 72. CSL Behring Business Overview Table 73. CSL Behring Hepatitis A immunoglobulin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. CSL Behring Hepatitis A immunoglobulin Product Portfolio Table 75. CSL Behring Recent Development Table 76. Dr. Reddy's Laboratories Company Information Table 77. Dr. Reddy's Laboratories Business Overview Table 78. Dr. Reddy's Laboratories Hepatitis A immunoglobulin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Dr. Reddy's Laboratories Hepatitis A immunoglobulin Product Portfolio Table 80. Dr. Reddy's Laboratories Recent Development Table 81. Native Antigen Company Information Table 82. Native Antigen Business Overview Table 83. Native Antigen Hepatitis A immunoglobulin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Native Antigen Hepatitis A immunoglobulin Product Portfolio Table 85. Native Antigen Recent Development Table 86. AIM Vaccine Company Information Table 87. AIM Vaccine Business Overview Table 88. AIM Vaccine Hepatitis A immunoglobulin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. AIM Vaccine Hepatitis A immunoglobulin Product Portfolio Table 90. AIM Vaccine Recent Development Table 91. GSK Company Information Table 92. GSK Business Overview Table 93. GSK Hepatitis A immunoglobulin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. GSK Hepatitis A immunoglobulin Product Portfolio Table 95. GSK Recent Development Table 96. Sinovac Biotech Company Information Table 97. Sinovac Biotech Business Overview Table 98. Sinovac Biotech Hepatitis A immunoglobulin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Sinovac Biotech Hepatitis A immunoglobulin Product Portfolio Table 100. Sinovac Biotech Recent Development Table 101. Merck Company Information Table 102. Merck Business Overview Table 103. Merck Hepatitis A immunoglobulin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Merck Hepatitis A immunoglobulin Product Portfolio Table 105. Merck Recent Development Table 106. Pukang Biotechnology Company Information Table 107. Pukang Biotechnology Business Overview Table 108. Pukang Biotechnology Hepatitis A immunoglobulin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Pukang Biotechnology Hepatitis A immunoglobulin Product Portfolio Table 110. Pukang Biotechnology Recent Development Table 111. Sanofi Company Information Table 112. Sanofi Business Overview Table 113. Sanofi Hepatitis A immunoglobulin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Sanofi Hepatitis A immunoglobulin Product Portfolio Table 115. Sanofi Recent Development Table 116. Changchun Lnstitute Of Biological Products Company Information Table 117. Changchun Lnstitute Of Biological Products Business Overview Table 118. Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Product Portfolio Table 120. Changchun Lnstitute Of Biological Products Recent Development Table 121. Zhifei Biological Products Company Information Table 122. Zhifei Biological Products Business Overview Table 123. Zhifei Biological Products Hepatitis A immunoglobulin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Zhifei Biological Products Hepatitis A immunoglobulin Product Portfolio Table 125. Zhifei Biological Products Recent Development Table 126. North America Hepatitis A immunoglobulin Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 127. North America Hepatitis A immunoglobulin Sales by Country (2021-2026) & (Units) Table 128. North America Hepatitis A immunoglobulin Sales Market Share by Country (2021-2026) Table 129. North America Hepatitis A immunoglobulin Sales Forecast by Country (2027-2032) & (Units) Table 130. North America Hepatitis A immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 131. North America Hepatitis A immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Hepatitis A immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Hepatitis A immunoglobulin Market Share by Country (2021-2026) Table 134. North America Hepatitis A immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Hepatitis A immunoglobulin Market Share Forecast by Country (2027-2032) Table 136. Europe Hepatitis A immunoglobulin Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 137. Europe Hepatitis A immunoglobulin Sales by Country (2021-2026) & (Units) Table 138. Europe Hepatitis A immunoglobulin Sales Market Share by Country (2021-2026) Table 139. Europe Hepatitis A immunoglobulin Sales Forecast by Country (2027-2032) & (Units) Table 140. Europe Hepatitis A immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Hepatitis A immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Hepatitis A immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Hepatitis A immunoglobulin Market Share by Country (2021-2026) Table 144. Europe Hepatitis A immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Hepatitis A immunoglobulin Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Hepatitis A immunoglobulin Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Hepatitis A immunoglobulin Sales by Country (2021-2026) & (Units) Table 148. Asia-Pacific Hepatitis A immunoglobulin Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Hepatitis A immunoglobulin Sales Forecast by Country (2027-2032) & (Units) Table 150. Asia-Pacific Hepatitis A immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Hepatitis A immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Hepatitis A immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Hepatitis A immunoglobulin Market Share by Country (2021-2026) Table 154. Asia-Pacific Hepatitis A immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Hepatitis A immunoglobulin Market Share Forecast by Country (2027-2032) Table 156. Latin America Hepatitis A immunoglobulin Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 157. Latin America Hepatitis A immunoglobulin Sales by Country (2021-2026) & (Units) Table 158. Latin America Hepatitis A immunoglobulin Sales Market Share by Country (2021-2026) Table 159. Latin America Hepatitis A immunoglobulin Sales Forecast by Country (2027-2032) & (Units) Table 160. Latin America Hepatitis A immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Hepatitis A immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Hepatitis A immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Hepatitis A immunoglobulin Market Share by Country (2021-2026) Table 164. Latin America Hepatitis A immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Hepatitis A immunoglobulin Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Hepatitis A immunoglobulin Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Hepatitis A immunoglobulin Sales by Country (2021-2026) & (Units) Table 168. Middle East and Africa Hepatitis A immunoglobulin Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Hepatitis A immunoglobulin Sales Forecast by Country (2027-2032) & (Units) Table 170. Middle East and Africa Hepatitis A immunoglobulin Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Hepatitis A immunoglobulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Hepatitis A immunoglobulin Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Hepatitis A immunoglobulin Market Share by Country (2021-2026) Table 174. Middle East and Africa Hepatitis A immunoglobulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Hepatitis A immunoglobulin Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Hepatitis A immunoglobulin Distributors List Table 179. Hepatitis A immunoglobulin Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Hepatitis A immunoglobulin Image Figure 2. Global Hepatitis A immunoglobulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hepatitis A immunoglobulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Hepatitis A immunoglobulin Sales (2021-2032) & (Units) Figure 5. Inactivated Image Figure 6. Global Inactivated Sales YoY Growth (2021-2032) & (Units) Figure 7. Attenuated Image Figure 8. Global Attenuated Sales YoY Growth (2021-2032) & (Units) Figure 9. Global Hepatitis A immunoglobulin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Hepatitis A immunoglobulin Market Share by Type 2025 VS 2032 Figure 11. North America Hepatitis A immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 12. North America Hepatitis A immunoglobulin Sales Market Share in Value by Type in 2025 Figure 13. Europe Hepatitis A immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Hepatitis A immunoglobulin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Hepatitis A immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Hepatitis A immunoglobulin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Hepatitis A immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Hepatitis A immunoglobulin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Hepatitis A immunoglobulin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Hepatitis A immunoglobulin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Hepatitis A immunoglobulin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (Units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (Units) Figure 29. Global Hepatitis A immunoglobulin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Hepatitis A immunoglobulin Market Share by Application 2025 VS 2032 Figure 31. North America Hepatitis A immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 32. North America Hepatitis A immunoglobulin Sales Market Share in Value by Application in 2025 Figure 33. Europe Hepatitis A immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 34. Europe Hepatitis A immunoglobulin Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Hepatitis A immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Hepatitis A immunoglobulin Sales Market Share in Value by Application in 2025 Figure 37. Latin America Hepatitis A immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Hepatitis A immunoglobulin Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Hepatitis A immunoglobulin Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Hepatitis A immunoglobulin Sales Market Share in Value by Application in 2025 Figure 41. North America Hepatitis A immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 42. North America Hepatitis A immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Hepatitis A immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Hepatitis A immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Hepatitis A immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 46. Europe Hepatitis A immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Hepatitis A immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Hepatitis A immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Hepatitis A immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 50. Asia-Pacific Hepatitis A immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Hepatitis A immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Hepatitis A immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Hepatitis A immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 54. Latin America Hepatitis A immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Hepatitis A immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Hepatitis A immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Hepatitis A immunoglobulin Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 58. Middle East and Africa Hepatitis A immunoglobulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Hepatitis A immunoglobulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Hepatitis A immunoglobulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Hepatitis A immunoglobulin Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Hepatitis A immunoglobulin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated
  • Attenuated
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • CSL Behring
  • Dr. Reddy's Laboratories
  • Native Antigen
  • AIM Vaccine
  • GSK
  • Sinovac Biotech
  • Merck
  • Pukang Biotechnology
  • Sanofi
  • Changchun Lnstitute Of Biological Products
  • Zhifei Biological Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hepatitis A immunoglobulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hepatitis A immunoglobulin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hepatitis A immunoglobulin Market by Type
  6. 1.3.1 Inactivated
  7. 1.3.2 Attenuated
  8. 1.4 Global Hepatitis A immunoglobulin Market Size by Type
  9. 1.4.1 Global Hepatitis A immunoglobulin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Hepatitis A immunoglobulin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Hepatitis A immunoglobulin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Hepatitis A immunoglobulin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Hepatitis A immunoglobulin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Hepatitis A immunoglobulin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Hepatitis A immunoglobulin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Hepatitis A immunoglobulin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hepatitis A immunoglobulin Industry Trends
  2. 2.2 Hepatitis A immunoglobulin Industry Drivers
  3. 2.3 Hepatitis A immunoglobulin Industry Opportunities and Challenges
  4. 2.4 Hepatitis A immunoglobulin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hepatitis A immunoglobulin Revenue (2021-2026)
  2. 3.2 Global Top Players by Hepatitis A immunoglobulin Sales (2021-2026)
  3. 3.3 Global Top Players by Hepatitis A immunoglobulin Price (2021-2026)
  4. 3.4 Global Hepatitis A immunoglobulin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hepatitis A immunoglobulin Major Company Production Sites & Headquarters
  6. 3.6 Global Hepatitis A immunoglobulin Company, Product Type & Application
  7. 3.7 Global Hepatitis A immunoglobulin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hepatitis A immunoglobulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hepatitis A immunoglobulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hepatitis A immunoglobulin Tier 1, Tier 2, and Tier 3
4 Hepatitis A immunoglobulin Regional Status and Outlook
  1. 4.1 Global Hepatitis A immunoglobulin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hepatitis A immunoglobulin Historic Market Size by Region
  3. 4.2.1 Global Hepatitis A immunoglobulin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hepatitis A immunoglobulin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hepatitis A immunoglobulin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hepatitis A immunoglobulin Forecasted Market Size by Region
  7. 4.3.1 Global Hepatitis A immunoglobulin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hepatitis A immunoglobulin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hepatitis A immunoglobulin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hepatitis A immunoglobulin by Application
  1. 5.1 Hepatitis A immunoglobulin Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Hepatitis A immunoglobulin Market Size by Application
  6. 5.2.1 Global Hepatitis A immunoglobulin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Hepatitis A immunoglobulin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Hepatitis A immunoglobulin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Hepatitis A immunoglobulin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Hepatitis A immunoglobulin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Hepatitis A immunoglobulin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Hepatitis A immunoglobulin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Hepatitis A immunoglobulin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSL Behring
  2. 6.1.1 CSL Behring Company Information
  3. 6.1.2 CSL Behring Business Overview
  4. 6.1.3 CSL Behring Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSL Behring Hepatitis A immunoglobulin Product Portfolio
  6. 6.1.5 CSL Behring Recent Developments
  7. 6.2 Dr. Reddy's Laboratories
  8. 6.2.1 Dr. Reddy's Laboratories Company Information
  9. 6.2.2 Dr. Reddy's Laboratories Business Overview
  10. 6.2.3 Dr. Reddy's Laboratories Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Dr. Reddy's Laboratories Hepatitis A immunoglobulin Product Portfolio
  12. 6.2.5 Dr. Reddy's Laboratories Recent Developments
  13. 6.3 Native Antigen
  14. 6.3.1 Native Antigen Company Information
  15. 6.3.2 Native Antigen Business Overview
  16. 6.3.3 Native Antigen Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Native Antigen Hepatitis A immunoglobulin Product Portfolio
  18. 6.3.5 Native Antigen Recent Developments
  19. 6.4 AIM Vaccine
  20. 6.4.1 AIM Vaccine Company Information
  21. 6.4.2 AIM Vaccine Business Overview
  22. 6.4.3 AIM Vaccine Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AIM Vaccine Hepatitis A immunoglobulin Product Portfolio
  24. 6.4.5 AIM Vaccine Recent Developments
  25. 6.5 GSK
  26. 6.5.1 GSK Company Information
  27. 6.5.2 GSK Business Overview
  28. 6.5.3 GSK Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GSK Hepatitis A immunoglobulin Product Portfolio
  30. 6.5.5 GSK Recent Developments
  31. 6.6 Sinovac Biotech
  32. 6.6.1 Sinovac Biotech Company Information
  33. 6.6.2 Sinovac Biotech Business Overview
  34. 6.6.3 Sinovac Biotech Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sinovac Biotech Hepatitis A immunoglobulin Product Portfolio
  36. 6.6.5 Sinovac Biotech Recent Developments
  37. 6.7 Merck
  38. 6.7.1 Merck Company Information
  39. 6.7.2 Merck Business Overview
  40. 6.7.3 Merck Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merck Hepatitis A immunoglobulin Product Portfolio
  42. 6.7.5 Merck Recent Developments
  43. 6.8 Pukang Biotechnology
  44. 6.8.1 Pukang Biotechnology Company Information
  45. 6.8.2 Pukang Biotechnology Business Overview
  46. 6.8.3 Pukang Biotechnology Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pukang Biotechnology Hepatitis A immunoglobulin Product Portfolio
  48. 6.8.5 Pukang Biotechnology Recent Developments
  49. 6.9 Sanofi
  50. 6.9.1 Sanofi Company Information
  51. 6.9.2 Sanofi Business Overview
  52. 6.9.3 Sanofi Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sanofi Hepatitis A immunoglobulin Product Portfolio
  54. 6.9.5 Sanofi Recent Developments
  55. 6.10 Changchun Lnstitute Of Biological Products
  56. 6.10.1 Changchun Lnstitute Of Biological Products Company Information
  57. 6.10.2 Changchun Lnstitute Of Biological Products Business Overview
  58. 6.10.3 Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Changchun Lnstitute Of Biological Products Hepatitis A immunoglobulin Product Portfolio
  60. 6.10.5 Changchun Lnstitute Of Biological Products Recent Developments
  61. 6.11 Zhifei Biological Products
  62. 6.11.1 Zhifei Biological Products Company Information
  63. 6.11.2 Zhifei Biological Products Business Overview
  64. 6.11.3 Zhifei Biological Products Hepatitis A immunoglobulin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Zhifei Biological Products Hepatitis A immunoglobulin Product Portfolio
  66. 6.11.5 Zhifei Biological Products Recent Developments
7 North America by Country
  1. 7.1 North America Hepatitis A immunoglobulin Sales by Country
  2. 7.1.1 North America Hepatitis A immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hepatitis A immunoglobulin Sales by Country (2021-2026)
  4. 7.1.3 North America Hepatitis A immunoglobulin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hepatitis A immunoglobulin Market Size by Country
  6. 7.2.1 North America Hepatitis A immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hepatitis A immunoglobulin Market Size by Country (2021-2026)
  8. 7.2.3 North America Hepatitis A immunoglobulin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hepatitis A immunoglobulin Sales by Country
  2. 8.1.1 Europe Hepatitis A immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hepatitis A immunoglobulin Sales by Country (2021-2026)
  4. 8.1.3 Europe Hepatitis A immunoglobulin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hepatitis A immunoglobulin Market Size by Country
  6. 8.2.1 Europe Hepatitis A immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hepatitis A immunoglobulin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hepatitis A immunoglobulin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hepatitis A immunoglobulin Sales by Country
  2. 9.1.1 Asia-Pacific Hepatitis A immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hepatitis A immunoglobulin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hepatitis A immunoglobulin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hepatitis A immunoglobulin Market Size by Country
  6. 9.2.1 Asia-Pacific Hepatitis A immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hepatitis A immunoglobulin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hepatitis A immunoglobulin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hepatitis A immunoglobulin Sales by Country
  2. 10.1.1 South America Hepatitis A immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hepatitis A immunoglobulin Sales by Country (2021-2026)
  4. 10.1.3 South America Hepatitis A immunoglobulin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hepatitis A immunoglobulin Market Size by Country
  6. 10.2.1 South America Hepatitis A immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hepatitis A immunoglobulin Market Size by Country (2021-2026)
  8. 10.2.3 South America Hepatitis A immunoglobulin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hepatitis A immunoglobulin Sales by Country
  2. 11.1.1 Middle East and Africa Hepatitis A immunoglobulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hepatitis A immunoglobulin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hepatitis A immunoglobulin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hepatitis A immunoglobulin Market Size by Country
  6. 11.2.1 Middle East and Africa Hepatitis A immunoglobulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hepatitis A immunoglobulin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hepatitis A immunoglobulin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hepatitis A immunoglobulin Value Chain Analysis
  2. 12.1.1 Hepatitis A immunoglobulin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hepatitis A immunoglobulin Production Mode & Process
  7. 12.2 Hepatitis A immunoglobulin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hepatitis A immunoglobulin Distributors
  10. 12.2.3 Hepatitis A immunoglobulin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst